Concentrations of Mitomycin C in Rabbit Corneal Tissue and Aqueous Humor After Topical Administration

Purpose: To study the aqueous and corneal pharmacokinetics of mitomycin C (MMC) after single topical administration to the central cornea and to evaluate the effects of different concentrations and different application times on the aqueous concentration of MMC. Methods: Mechanical epithelium debridement of the central 7.5 mm of the cornea was performed in New Zealand white rabbits, and a sponge soaked in 0.02% MMC solution was placed on the denuded corneal stroma for 2 minutes. Aqueous fluid and central corneal tissues samples were taken at 0.5, 1, 2, and 3 hours thereafter. MMC concentration of the samples was analyzed by high-performance liquid chromatography and evaluated at different exposure times (range: 15-120 seconds) and concentrations of applied MMC (range: 0.005%-0.04%). Results: Peak corneal concentration was 3.728 ± 2.547 μg/g at 30 minutes after topical administration. Maximum aqueous concentration was 0.380 ± 0.038 μg/mL at 1 hour after topical application. The aqueous concentration of MMC increased in a dose-dependent manner with increasing exposure time and application concentration. Aqueous MMC concentration increased at a higher rate with change of applied concentration than with exposure time. Conclusion: Good penetration of MMC through central bare cornea may be noxious to endothelial cells. Reducing concentration or decreasing exposure time seems a good modality to reduce potential MMC toxicity.

[1]  Shu-Wen Chang Corneal keratocyte apoptosis following topical intraoperative mitomycin C in rabbits. , 2005, Journal of refractive surgery.

[2]  P. Majmudar,et al.  How and when to use mitomycin-C in refractive surgery , 2005, Current opinion in ophthalmology.

[3]  Edoardo Midena,et al.  Mitomycin C modulation of corneal wound healing after photorefractive keratectomy in highly myopic eyes. , 2005, Ophthalmology.

[4]  R. Pfister Permanent corneal edema resulting from the treatment of PTK corneal haze with mitomycin: a case report. , 2004, Cornea.

[5]  Massimo Camellin Laser epithelial keratomileusis with mitomycin C: indications and limits. , 2004, Journal of refractive surgery.

[6]  Shu-Wen Chang Early corneal edema following topical application of mitomycin‐C , 2004, Journal of cataract and refractive surgery.

[7]  Y. Lai,et al.  Mitomycin C alters corneal stromal wound healing and corneal haze in rabbits after argon-fluoride excimer laser photorefractive keratectomy. , 2004, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[8]  K. Sung,et al.  Apoptosis in keratocytes caused by mitomycin C. , 2003, Investigative ophthalmology & visual science.

[9]  Francesco Carones,et al.  Evaluation of the prophylactic use of mitomycin‐C to inhibit haze formation after photorefractive keratectomy , 2002, Journal of cataract and refractive surgery.

[10]  H Xu,et al.  Mitomycin C reduces haze formation in rabbits after excimer laser photorefractive keratectomy. , 2001, Journal of refractive surgery.

[11]  C. Vass,et al.  Impact of Mitomycin-C application time on the scleral Mitomycin-C concentration. , 2001, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[12]  M. Deist,et al.  Iatrogenic keratectasia after laser in situ keratomileusis for less than -4.0 to -7.0 diopters of myopia. , 2000, Journal of cataract and refractive surgery.

[13]  C. Vass,et al.  Intrascleral concentration vs depth profile of mitomycin-C after episcleral application: impact of applied concentration and volume of mitomycin-C solution. , 2000, Experimental eye research.

[14]  T. Mcmahon,et al.  Iatrogenic keratoconus: corneal ectasia following laser in situ keratomileusis for myopia. , 2000, Archives of ophthalmology.

[15]  C. Joo,et al.  Corneal ectasia detected after laser in situ keratomileusis for correction of less than -12 diopters of myopia. , 2000, Journal of cataract and refractive surgery.

[16]  P. Majmudar,et al.  Topical mitomycin-C for subepithelial fibrosis after refractive corneal surgery. , 2000, Ophthalmology.

[17]  T. Seiler,et al.  Iatrogenic keratectasia after laser in situ keratomileusis. , 1998, Journal of refractive surgery.

[18]  B Seitz,et al.  In vitro effects of mitomycin-C on human keratocytes. , 1996, Journal of refractive surgery.

[19]  M. Wilson,et al.  Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. , 1997, American journal of ophthalmology.

[20]  R. D. Stulting,et al.  Treatment of recurrent conjunctival epithelial neoplasia with topical mitomycin C. , 1997, American journal of ophthalmology.

[21]  J. Gebbers,et al.  Mitomycin C reduces scar formation after excimer laser (193 nm) photorefractive keratectomy in rabbits , 1997, Eye.

[22]  M. Wilson,et al.  Aqueous and vitreous concentration of mitomycin C by topical administration after glaucoma filtration surgery in rabbits. , 1993, Ophthalmology.

[23]  P. S. Mahar,et al.  Role of mitomycin C in pterygium surgery. , 1993, The British journal of ophthalmology.

[24]  S. Hayasaka,et al.  Corneoscleral ulceration and corneal perforation after pterygium excision and topical mitomycin C therapy. , 1993, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.

[25]  Y. Kitazawa,et al.  Mitomycin concentration in rabbit and human ocular tissues after topical administration. , 1992, Ophthalmology.

[26]  W. Green,et al.  Modulation of corneal wound healing after excimer laser keratomileusis using topical mitomycin C and steroids. , 1991, Archives of ophthalmology.

[27]  S. Bechara American Society of Cataract and Refractive Surgery , 1991 .

[28]  S. Palmer,et al.  Mitomycin as adjunct chemotherapy with trabeculectomy. , 1991, Ophthalmology.

[29]  M. Wilson,et al.  Mitomycin eye drops as treatment for pterygium. , 1988, Ophthalmology.